Wellbutrin SRĀ®, a brand name of bupropion SR, is a sustained release version of bupropion, a norepinephrine and dopamine reuptake inhibitor (NDRI) used to treat major depressive disorder, including seasonal affective disorder (SAD).
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Depression | 18 |
|
|
|
3 | ||
| Fatigue | 4 |
|
1 | ||||
| PAIN & FATIGUE | 2 |
|
1 | ||||
| Pain | 2 | 0 | |||||
| Other | 1 |
|
1 | ||||
| Obsessive compulsive disorder OCD | 1 | 0 |
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
3 | 50% |
|
|
Doctor's advice
|
2 | 33% |
|
|
Other
|
2 | 33% |
|
|
Expense
|
1 | 17% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 22, 2009.